| SpectraBase Spectrum ID |
DlKX0XqLAzQ |
| Name |
1-(Cyclohexylmethyl)-2-[(4-ethoxyphenyl)methyl]-N,N-diethyl-1H-benzimidazol-5-carboxamide |
| Classification |
Benzimidazol cannabinoid designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
447.288577441 u |
| Formula |
C28H37N3O2 |
| InChI |
InChI=1S/C28H37N3O2/c1-4-30(5-2)28(32)23-14-17-26-25(19-23)29-27(31(26)20-22-10-8-7-9-11-22)18-21-12-15-24(16-13-21)33-6-3/h12-17,19,22H,4-11,18,20H2,1-3H3 |
| InChIKey |
WRVZBXHTUOPQJS-UHFFFAOYSA-N |
| Ionization Type |
Chemical Ionization (CI) |
| Molecular Weight |
447.623 g/mol |
| Nominal Mass |
447 u |
| Reagent Gas |
Methane |
| Retention Index |
3836 |
| SMILES |
C=12N(C(=NC2=CC(C(N(CC)CC)=O)=CC1)CC1=CC=C(C=C1)OCC)CC1CCCCC1 |
| SPLASH |
splash10-0002-0001900000-88cb73a40676e5f5d695 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
1-(cyclohexylmethyl)-2-(4-ethoxybenzyl)-N,N-diethyl-1H-benzimidazole-5-carboxamide |
| Technique |
GC/MS |
| Wiley ID |
DD2024_017988 |
